These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7882142)

  • 1. In vitro selection of antisense oligonucleotides targeted to a hairpin structure.
    Mishra RK; Toulmé JJ
    C R Acad Sci III; 1994 Nov; 317(11):977-82. PubMed ID: 7882142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational and combinatorial strategies for designing oligonucleotides targeted to RNA structures.
    Toulmé JJ; Le Tinévez R; Boiziau C; Dausse E
    Nucleic Acids Symp Ser; 1997; (36):39-41. PubMed ID: 9478200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target selection for antisense oligonucleotide induced exon skipping in the dystrophin gene.
    Errington SJ; Mann CJ; Fletcher S; Wilton SD
    J Gene Med; 2003 Jun; 5(6):518-27. PubMed ID: 12797117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA hairpin invasion and ribosome elongation arrest by mixed base PNA oligomer.
    Dias N; Sénamaud-Beaufort C; Forestier El El; Auvin C; Hélène C; Ester Saison-Behmoaras T
    J Mol Biol; 2002 Jul; 320(3):489-501. PubMed ID: 12096905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hairpin antisense oligonucleotides containing 2'-methoxynucleosides with base-pairing in the stem region at the 3'-end: penetration, localization, and Anti-HIV activity.
    Kuwasaki T; Hosono K; Takai K; Ushijima K; Nakashima H; Saito T; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 1996 Nov; 228(2):623-31. PubMed ID: 8920960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new enzymatic route for production of long 5'-phosphorylated oligonucleotides using suicide cassettes and rolling circle DNA synthesis.
    Lohmann JS; Stougaard M; Koch J
    BMC Biotechnol; 2007 Aug; 7():49. PubMed ID: 17705815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulating eukaryotic gene expression with aptamers.
    Toulmé JJ; Di Primo C; Boucard D
    FEBS Lett; 2004 Jun; 567(1):55-62. PubMed ID: 15165893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LNA-modified oligonucleotides effectively drive intramolecular-stable hairpin to intermolecular-duplex state.
    Kaur H; Wengel J; Maiti S
    Biochem Biophys Res Commun; 2007 Jan; 352(1):118-22. PubMed ID: 17107660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Properties of nicked and circular dumbbell RNA-DNA chimeric oligonucleotides.
    Yamakawa H; Hosono K; Ishibashi T; Takai K; Takaku H
    Nucleic Acids Symp Ser; 1995; (34):133-4. PubMed ID: 8841588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of bacterial RNase P RNA as a drug target.
    Willkomm DK; Gruegelsiepe H; Goudinakis O; Kretschmer-Kazemi Far R; Bald R; Erdmann VA; Hartmann RK
    Chembiochem; 2003 Oct; 4(10):1041-8. PubMed ID: 14523922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antisense micF RNA and 5'-UTR of the target ompF RNA: phylogenetic conservation of primary and secondary structures.
    Delihas N
    Nucleic Acids Symp Ser; 1997; (36):33-5. PubMed ID: 9478198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense tumor therapy (a dream under construction).
    Kopper L; Kovalszky I
    In Vivo; 1994; 8(5):781-6. PubMed ID: 7727725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aptamers targeted to an RNA hairpin show improved specificity compared to that of complementary oligonucleotides.
    Darfeuille F; Reigadas S; Hansen JB; Orum H; Di Primo C; Toulmé JJ
    Biochemistry; 2006 Oct; 45(39):12076-82. PubMed ID: 17002307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
    Delihas N; Rokita SE; Zheng P
    Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of gene expression by targeted disruption of messenger RNA: available options and current strategies.
    Jen KY; Gewirtz AM
    Stem Cells; 2000; 18(5):307-19. PubMed ID: 11007915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.
    Mishra RK; Le Tinévez R; Toulmé JJ
    Proc Natl Acad Sci U S A; 1996 Oct; 93(20):10679-84. PubMed ID: 8855239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel integrated strategy (full length gene targeting) for mRNA accessible site tagging combined with microarray hybridization/RNase H cleavage to screen effective antisense oligonucleotides.
    Sun Y; Duan M; Lin R; Wang D; Li C; Bo X; Wang S
    Mol Vis; 2006 Nov; 12():1364-71. PubMed ID: 17149362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection of antisense oligodeoxynucleotides against glutathione S-transferase Mu.
    't Hoen PA; Out R; Commandeur JN; Vermeulen NP; van Batenburg FH; Manoharan M; van Berkel TJ; Biessen EA; Bijsterbosch MK
    RNA; 2002 Dec; 8(12):1572-83. PubMed ID: 12515389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of HIV-1 replication by a new type of circular dumbbell RNA/DNA chimeric oligonucleotides.
    Park WS; Miyano-Kurosaki N; Abe T; Takai K; Yamamoto N; Takaku H
    Biochem Biophys Res Commun; 2000 Apr; 270(3):953-60. PubMed ID: 10772932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.